Method of inhibiting fibrosis with a somatostatin agonist
US6268342A · kind A · utility
13Cited by
1References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 1999 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | May 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of inhibiting fibrosis in a patient. The method comprises administering a therapeutically effective amount of a somatostatin, a somatostatin agonist or apharmaceutically acceptable salt thereof to said patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.